4//SEC Filing
Cundy Kenneth C 4
Accession 0001493152-24-008613
CIK 0001815974other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 6:24 PM ET
Size
5.5 KB
Accession
0001493152-24-008613
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-29+72,613→ 72,613 totalExercise: $2.78Exp: 2034-02-28→ Common Stock (72,613 underlying)
Footnotes (1)
- [F1]The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001322959
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 6:24 PM ET
- Size
- 5.5 KB